Have you heard the one about a market so hot that you could sell ice to Native Alaskans during the winter? Well, it’s only a joke because you can’t sell anything to customers who get it for free, courtesy of the climate. On the other hand, during August, when the Alaskan sun rises before 5:15 […]
Quantive is pleased to announce that we recently advised Biopharma Global (Biopharma) on its sale to Pace® Life Sciences, LLC. Minneapolis-based Pace® Life Sciences, LLC, a full-service contract development and manufacturing organization (CDMO) and a subsidiary of Pace®, a science and technology company, announced earlier this month that it has acquired Biopharma Global (Biopharma). Biopharma specializes […]
One of the things we like to talk about is trends. Trending in revenue. Trending in an industry. Trending in technology. So reading this piece in Forbes fits right in our bailiwick. Jeffrey Greene – who’s a pretty smart guy – suggests that technology is the largest threat to the white-collar sector. Interesting, right? And he’s […]
Ok, I admit it. Uber is our darling here. We tend to go on and on both about valuation issues and what a unique business model it is. Here we have a company that is looking to raise capital at a $50bn valuation, and it’s core business model is to basically use other people’s idle […]
The NFL is one of America’s most visible brands- and far and away the biggest sporting draw. The league earns an estimated $10 billion or more per year in revenue. In 2013, an estimated 1.7 billion viewers watched NFL games on the 4 major networks carrying the NFL. But despite the fanfare – and despite […]
Quantive is a veteran owned and operated financial services firm. We work exclusively on matters related to corporate value: business valuation, value growth, and M&A advisory.